Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19

Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19

Abstract Background Venous thromboembolism (VTE) risk is increased in patients with COVID‐19 infection. Understanding which patients are likely to develop VTE may inform pharmacologic VTE prophylaxis decision making. The hospital‐associated venous thromboembolism–Intermountain Risk Score (HA‐VTE IMR...

Full description

Bibliographic Details
Main Authors: Scott C. Woller, Scott M. Stevens, Joseph R. Bledsoe, Masarret Fazili, James F. Lloyd, Greg L. Snow, Benjamin D. Horne
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
biomarker
bleeding
risk score
thrombosis
venous thromboembolism
Online Access:https://doi.org/10.1002/rth2.12765

Internet

https://doi.org/10.1002/rth2.12765

Similar Items